Literature DB >> 6457792

Delayed hypersensitivity to Trypanosoma cruzi in mice: specific suppressor cells in chronic infection.

M T Scott.   

Abstract

In mice chronically infected with Trypanosoma cruzi there are antigen-specific suppressor cells which inhibit the development of delayed hypersensitivity (DTH) to T. cruzi antigen but not to an unrelated antigen, keyhole limpet haemocyanin (KLH). This was shown by comparing the 24 hr footpad reactivity, elicited by injection of soluble T. cruzi antigen, of infected mice with that of mice immunized with killed T. cruzi antigen after pretreatment with cyclophosphamide. In the latter, 24 hr footpad swelling represented a DTH reaction in that the cellular infiltrate was predominantly mononuclear and the reactivity could be transferred to normal recipients by lymphoid cells but not by serum. Chronically-infected mice also developed 24 hr footpad swelling but the fact that this was undiminished from an earlier 3 hr reaction and could not be transferred to normal recipients by either local or systemic injection of cells, as well as the histological features, all implied that it represented a prolonged Arthus reaction. The absence or minimal levels of specific DTH detectable in chronic T. cruzi infected mice was accompanied by the presence in their spleens of cells which specifically suppressed the generation of DTH to T. cruzi in normal mice. Suppressor cell activity was radioresistant (10 Gy/1000 rad) and T-cell mediated as defined by significantly decreased and increased suppression following anti-Thy 1.2 serum treatment and nylon wool fractionation, respectively. The ability of chronic T. cruzi mice to develop DTH to an unrelated antigen KLH was unimpaired.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457792      PMCID: PMC1555205     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity.

Authors:  I A Ramshaw; P A Bretscher; C R Parish
Journal:  Eur J Immunol       Date:  1976-10       Impact factor: 5.532

2.  Stearic acid, an essential growth factor for Trypanosoma cruzi.

Authors:  G J BONE; G PARENT
Journal:  J Gen Microbiol       Date:  1963-05

3.  Cellular immunity to Trypanosoma cruzi infection in mice.

Authors:  A P Reis; C A Chiari; R Tanus; I M Andrade
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1976 Nov-Dec       Impact factor: 1.846

4.  Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.

Authors:  F Kierszenbaum; J G Howard
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

5.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

6.  Delayed hypersensitivity in Trypanosoma cruzi infection.

Authors:  S Seah
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

7.  Use of 125I-labelled albumin for the detection and measurement of delayed-hypersensitivity reactions in the mouse.

Authors:  M F Franco; J Morley
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

8.  Protective effects of specific antibodies in Trypanosoma cruzi infections.

Authors:  A U Krettli; Z Brener
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

9.  The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens.

Authors:  A R Teixeira; C A Santos-Buch
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

10.  Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum.

Authors:  N McHardy
Journal:  Tropenmed Parasitol       Date:  1977-06
View more
  7 in total

1.  Development of specific and cross-reactive lymphocyte proliferative responses during chronic immunizing infections with Rickettsia tsutsugamushi.

Authors:  T R Jerrells; J V Osterman
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

2.  Analysis of the mechanism of immunodepression following heterologous antigenic stimulation during concurrent infection with Nematospiroides dubius.

Authors:  D I Pritchard; N M Ali; J M Behnke
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

3.  Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors:  M Castés; A Agnelli; A J Rondón
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients.

Authors:  M T Scott; M Goss-Sampson
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

5.  Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.

Authors:  Z A Andrade; S G Andrade; M Sadigursky
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

6.  Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

7.  Absence of immunosuppression in DBA/2 mice vaccinated with Trypanosoma cruzi treated with actinomycin-D.

Authors:  M Queiroz da Cruz; H M Bräscher; J R Vargens; L C Maia; A Oliveira-Lima
Journal:  Experientia       Date:  1989-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.